Tirzepatide has a half-life of approximately five days, meaning therapeutic levels decline gradually over several days to weeks after a missed injection rather than disappearing immediately
Since obesity is the largest epidemic in the world and affects hundreds of millions of people, the ability to treat it with a medication is an incredible development
Millar AD, Rampton DS, Chander CL, Claxson AWD, Blades S, Coumbe A, Panetta J, Morris CJ, and Blake DR (1996)
We have no membership fees or hidden costswhat you see is what you pay
By the 12 to 16-week mark, many individuals experience the full effects, which can include a significant reduction in body weight, often around 5% to 10% or more of their starting weight